XML 51 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Impact of Adoption of Accounting Guidance on Prior Years Presentation and Disclosures (Notes)
12 Months Ended
Dec. 31, 2018
Accounting Changes and Error Corrections [Abstract]  
Impact of adoption of accounting guidance on prior years’ presentation and disclosures
Impact of adoption of accounting guidance on prior years’ presentation and disclosures
Effective January 1, 2018, the Company adopted ASU No. 2017-07, Compensation - Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Post Retirement Benefit Cost. Accordingly, for 2017 and 2016, the Company retrospectively included only the service cost component of the net periodic benefit cost in the same line item or items on the consolidated statements of income as other compensation costs arising from services rendered by the respective employees during the period. The other components of net periodic benefit cost, which included interest cost, expected return on plan assets and amortization of actuarial gains/loss, were reclassified from “Cost of revenues”, “General and administrative expenses” and “Selling and marketing expenses” to “Other income, net”.
The effect of the adoption of ASU No. 2017-07 (Topic 715) on 2017 and 2016 financial information is summarized as follows:
 
 
Year ended December 31,
 
Year ended December 31,
 
 
2017
 
2016
 
 
Previously reported
 
As revised
 
Effect of change Increase/(Decrease)
 
Previously reported
 
As revised
 
Effect of change Increase/(Decrease)
Location in consolidated statements of income
 
 
 
 
 
 
 
 
 
 
 
 
Cost of revenues
 
$
495,586

 
$
495,142

 
$
(444
)
 
$
447,956

 
$
447,718

 
$
(238
)
General and administrative expenses
 
$
102,567

 
$
102,515

 
$
(52
)
 
$
88,648

 
$
88,616

 
$
(32
)
Selling and marketing expenses
 
$
53,383

 
$
53,379

 
$
(4
)
 
$
50,582

 
$
50,579

 
$
(3
)
Other income, net
 
$
11,859

 
$
11,359

 
$
(500
)
 
$
15,408

 
$
15,135

 
$
(273
)



 
 
Year ended December 31,
 
Year ended December 31,
 
 
2017
 
2016
 
 
Cost of revenues previously reported
 
Cost of revenues as revised
 
Effect of change Increase/(Decrease)
 
Cost of revenues previously reported
 
Cost of revenues as revised
 
Effect of change Increase/(Decrease)
Segment information (refer Note 3)
 
 
 
 
 
 
 
 
 
 
 
 
Insurance
 
$
159,529

 
$
159,433

 
$
(96
)
 
$
146,203

 
$
146,151

 
$
(52
)
Healthcare
 
$
49,483

 
$
49,412

 
$
(71
)
 
$
44,098

 
$
44,060

 
$
(38
)
TT&L
 
$
41,409

 
$
41,337

 
$
(72
)
 
$
41,962

 
$
41,923

 
$
(39
)
F&A
 
$
51,445

 
$
51,362

 
$
(83
)
 
$
48,302

 
$
48,258

 
$
(44
)
All Other
 
$
56,697

 
$
56,638

 
$
(59
)
 
$
61,050

 
$
61,019

 
$
(31
)
Analytics
 
$
137,023

 
$
136,960

 
$
(63
)
 
$
106,341

 
$
106,307

 
$
(34
)
Operating Expenses
 
$
194,499

 
$
194,443

 
$
(56
)
 
$
173,810

 
$
173,775

 
$
(35
)
Foreign exchange gain, interest expense and other income, net
 
$
12,809

 
$
12,309

 
$
(500
)
 
$
19,662

 
$
19,389

 
$
(273
)


Effective January 1, 2018, the Company adopted ASU 2016-18, Statements of Cash Flows (Topic 230), Restricted Cash. Accordingly, for 2017 and 2016, restricted cash and restricted cash equivalents is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the consolidated statements of cash flows.

The effect of the adoption of ASU No. 2016-18 (Topic 230) on 2017 and 2016 financial information is summarized as follows:
 
 
Year ended December 31,
 
Year ended December 31,
 
 
2017
 
2016
 
 
Previously reported
 
As revised
 
Effect of change Increase/(Decrease)
 
Previously reported
 
As revised
 
Effect of change Increase/(Decrease)
Consolidated statements of cash flows
 
 
 
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
 
$
113,140

 
$
113,159

 
$
19

 
$
100,258

 
$
102,395

 
$
2,137

Effect of exchange rate changes on cash, cash equivalents and restricted cash
 
$
3,711

 
$
3,935

 
$
224

 
$
(5,033
)
 
$
(5,122
)
 
$
(89
)
Net increase/(decrease) in cash, cash equivalents and restricted cash
 
$
(126,360
)
 
$
(126,117
)
 
$
243

 
$
7,832

 
$
9,880

 
$
2,048

Cash, cash equivalents and restricted cash - beginning of year
 
$
213,155

 
$
220,394

 
$
7,239

 
$
205,323

 
$
210,514

 
$
5,191

Cash, cash equivalents and restricted cash - end of year
 
$
86,795

 
$
94,277

 
$
7,482

 
$
213,155

 
$
220,394

 
$
7,239